Literature DB >> 21440921

Review of enteric outbreaks in prisons: effective infection control interventions.

J D Greig1, M B Lee, J E Harris.   

Abstract

OBJECTIVES: To identify documented outbreaks, worldwide, of enteric illness in correctional facilities over the last 10 years to understand the epidemiology of the outbreaks and explicitly identify effective infection control measures. STUDY
DESIGN: Review of literature and outbreak investigation reports.
METHODS: Computer-aided searches of literature databases and systematic searches of government websites were completed to identify relevant outbreak reports. Reference lists were hand-searched to validate the electronic search methodology. Reports identified through personal communications with public health officials were also included.
RESULTS: Of the 72 outbreaks meeting the inclusion criteria, 76% and 21% were associated with bacterial agents and viral agents, respectively. The majority of outbreaks were associated with Salmonella (n=20), Clostridium perfringens (n=14), norovirus (n=14), pathogenic Escherichia coli (n=10) and Campylobacter spp. (n=5). Transmission was primarily foodborne (67%). During an outbreak, the most common control measures included limiting movements of ill inmates and staff, and their exclusion from kitchen duty. The most common retrospectively reported preventative recommendations included monitoring food temperatures and effective infection control procedures.
CONCLUSIONS: It is essential to monitor food temperatures to prevent enteric outbreaks in prisons. Training in safe food handling should be offered to inmates who work in the kitchen. Enteric outbreaks are best controlled by effective infection control practices, while active surveillance and early diagnosis may prevent further spread of illness. Crown
Copyright © 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21440921     DOI: 10.1016/j.puhe.2010.12.006

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  6 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

Review 2.  Infection control for norovirus.

Authors:  L Barclay; G W Park; E Vega; A Hall; U Parashar; J Vinjé; B Lopman
Journal:  Clin Microbiol Infect       Date:  2014-07-16       Impact factor: 8.067

3.  Salmonella enterica serovar Enteritidis phage type 4 outbreak associated with eggs in a large prison, London 2009: an investigation using cohort and case/non-case study methodology.

Authors:  A R Davies; R Ruggles; Y Young; H Clark; P Reddell; N Q Verlander; A Arnold; H Maguire
Journal:  Epidemiol Infect       Date:  2012-07-17       Impact factor: 4.434

4.  High seroprevalence of Toxoplasma gondii infection in inmates: A case control study in Durango City, Mexico.

Authors:  C Alvarado-Esquivel; J Hernández-Tinoco; L F Sánchez-Anguiano; A Ramos-Nevárez; S M Cerrillo-Soto; L Sáenz-Soto; O Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

Review 5.  Key Dimensions for the Prevention and Control of Communicable Diseases in Institutional Settings: A Scoping Review to Guide the Development of a Tool to Strengthen Preparedness at Migrant Holding Centres in the EU/EEA.

Authors:  Flavia Riccardo; Jonathan E Suk; Laura Espinosa; Antonino Bella; Cristina Giambi; Martina Del Manso; Christian Napoli; Maria Grazia Dente; Gloria Nacca; Silvia Declich
Journal:  Int J Environ Res Public Health       Date:  2018-05-30       Impact factor: 3.390

6.  Multiple-serotype salmonella outbreaks in two state prisons--Arkansas, August 2012.

Authors:  Rachel E Gicquelais; Jamae F Morris; Stewart Matthews; Linda Gladden; Haytham Safi; Carla Grayson; Rachel B Slayton; Anna E Newton; Rebecca Bordonaro; J Gary Wheeler; Nathaniel Smith; Stacey A Bosch; Dirk T Haselow
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-02-28       Impact factor: 17.586

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.